Genomics in Africa Coming of Age

  • Register
    • Regular Member - Free!
    • Early Career Member - Free!
    • Resident/Clinical Fellow Member - Free!
    • Postdoctoral Fellow Member - Free!
    • Graduate Student Member - Free!
    • Undergraduate Student Member - Free!
    • Emeritus Member - Free!
    • Life Member - Free!
    • Trainee Member - Free!

Platform sessions are abstract driven sessions with 6 talks per session. These talks are 10 minutes in length and are cross-topical in nature to represent the broad discipline our field of genetics and genomics represent. After each talk, there will be a 5-minute Q&A with each speaker. For information on each individual session, please view the "Details" tab. 

Recorded session from the 2021 virtual meeting.

Key:

Complete
Failed
Available
Locked
Video
Open to view video.
Open to view video.

Revisiting the out of Africa event with a deep learning approach

Anatomically modern humans evolved around 300 thousand years ago in Africa. Modern humans started to appear in the fossil record outside of Africa about 100 thousand years ago though other hominins existed throughout Eurasia much earlier. Recently, several researchers argued in favourof a single out of Africa event for modern humans based on whole-genome sequences analyses. However, the single out of Africa model is in contrast with some of the findings from fossil records, which supports two out of Africa, and uniparental data, which proposes a back to Africa movement. Here, we used a deep learning approach coupled with Approximate Bayesian Computation and Sequential Monte Carlo to revisit these hypotheses from the whole genome sequence perspective. Our results support the back to Africa model over other alternatives. We estimated that there are two successive splits between Africa and out of African populations happening around 60-90 thousand years ago and separated by 13-15 thousand years. One of the populations resulting from the more recent split has to a large extent replaced the older West African population while the other one has founded the out of Africa populations.

Mayukh Mondal
Institute of Genomics, University of Tartu

An analysis of population copy number variation in sub-Saharan African genomes


Introduction Copy number variation (CNV) is responsible for a large component of normal human variation and has been implicated in the cause/genetic aetiology of several rare diseases. Population reference databases containing CNV information from all global populations is critical in disease genetics research, but current resources lack diversity, especially from the African continent. This makes such databases of limited use in studies looking at genetic diseases in African individuals. This study therefore aims to address this knowledge gap by producing a map of CNV using whole-genome data from several, previously unstudied African populations
Methods 1027 high coverage whole genome sequences obtained from individuals across west, central, southern and east Africa, were analysed using Manta and Graphtyper2. Additionally, 919 of the samples were also analysed using Genome STRiP to detect multi-allelic CNV. Quality control specific to each tool was performed in order to achieve high quality variant call sets.
Results 56 816 CNVs were detected by the Manta pipeline, consisting of 44 671 deletions and 12 145 duplications. Due the ability of Manta to detect small variants (<100bp), we are able to describe this previously less studied class of variants in an African cohort. 25% of the variants detected by Manta were <100 bp and 40% of these were common variants at >5% allele frequency. 50% of these variants are novel compared to 27% of the remaining variants >100bp. Overall, 32% of the variants identified were novel. A comparison between central, west, east and southern African regions yielded a number of variants unique to each region. We find deletions tend to have lower allele frequencies compared to duplications. The majority of variants were found in the non-coding genome, with only 8% of variants overlapping coding transcripts. An additional 5% of variants overlapped regulatory features. Genome STRiP detected 3991 multi-allelic variants with 99% having a copy number between 3-20. There were also variants with copy numbers greater than 20, some of which appear to be incidences of excessive runaway duplications not previously described.
Conclusion The amount of novel variation found demonstrates the importance of including African individuals from multiple African regions when producing reference databases and the rich genomic diversity of African genomes. Work is currently being performed to combine the full Genome STRiP and Manta call sets to produce a robust combined dataset. The variant database produced in this study will provide a valuable resource as a reference of normal CNV for the study of diseases in African populations.
Emma Wiener

Division of Human Genetics, National Health Laboratory Service & School of Pathology, Faculty of Health Sciences, University of Witwatersrand

Integrative genomic analyses identify key interethnic differences in immune response to malaria

Host responses to infection with the malaria parasite P. falciparum vary between individuals for reasons that are poorly understood. Here we reveal metabolic perturbations as a consequence of malaria infection in children and identify an immunosuppressive role of endogenous steroid production in the context of P. falciparum infection. We perform metabolomics on matched samples from children from two ethnic groups in West Africa, before and after infection with seasonal malaria. Analyzing 306 global metabolomes we identify 92 parasitemia-associated metabolites with impact on the host adaptive immune response. Integrative metabolomic-transcriptomic and causal mediation- moderation analyses reveal an infection-driven immunosuppressive role of parasitemia-associated pregnenolone steroids on lymphocyte function and the expression of key immunoregulatory lymphocyte genes in the Gouin ethnic group. In children from the less malaria-susceptible Fulani ethnic group we observe opposing responses upon infection, consistent with the immunosuppressive role of endogenous steroids in malaria. These findings advance our understanding of P. falciparum pathogenesis in humans and identify potential new targets for antimalarial therapeutic interventions. 

Youssef Idaghdour
New York University Abu Dhabi


GWAS of complex traits in a multi-population African cohort

The diversity among present-day African populations is the result of a deep and complex history of admixture, migrations, and regional adaptations to local environments and diseases. Little is known about the impact of this evolutionary history on the genetics underlying complex traits. Here I present recent work on genetic associations for a panel of anthropometric, cardiovascular, and metabolic biomarker measurements paired with dense genotyping data. For some traits, the variation among populations is expected to reflect local adaptations, such as short stature in western Cogo rainforest hunter-gatherers. The study cohort of several thousand individuals is drawn from an ancestrally diverse set of populations from western, eastern, and southern sub-Saharan Africa. Populations include current or recent hunter-gatherers, traditional agriculturalists, and semi-nomadic pastoralists, from rural regions of Cameroon, Nigeria, Ethiopia, Kenya, Tanzania, and Botswana. For many of these traits, this marks the first genotype/phenotype analysis to include these ethnic groups. The high degree of population structure presents both challenges and opportunities for genetic analysis. Genetic structure analysis indicates genetic clustering by geographic location, language family, and regional hunter-gatherer lineages. Examples include the hunter-gathers from the Serengeti, western Congo, and Kalahari, and clusters that correlate with Niger-Congo, Afroasiatic, and Nilo-Saharan language families. We observe substantial population-level variation for many traits, such as height, skin pigmentation, and blood pressure. The proportion of the trait variance that is due to the genetic population structure varies by trait and tends to be greater for anthropometric traits like height and skin pigmentation than for metabolic biomarkers like LDL. From genotype/phenotype association tests we find numerous independent associations at genome-wide significance for several traits, including circulating triglyceride levels and BMI. The population structure of the total additive genetic effects is also examined. European GWAS associations replicate poorly in this African cohort, while associations discovered in the African cohort show comparatively better replication in Europeans. 

Matthew Hansen
Univ Pennsylvania

Genotype-by-infection interactions: Single cell RNASeq profiling of in-vivo host immune response to malaria reveals cell type and infection-specific eQTLs

The disease burden of malaria remains a significant global public health challenge. Plasmodium falciparum is responsible for more than 99% of malaria cases in Africa and for >400,000/year malaria-related deaths worldwide. Inter-individual differences in susceptibility to malaria is multifactorial and has a significant heritable component but our understanding of the effect of infection on gene regulation of immune response at the transcriptional remains very limited. Here we use longitudinal matched sampling, single cell RNAseq profiling of PBMCs and whole-genome sequencing data of malarial children before and after natural P. falciparum infection in Banfora, Burkina Faso, West Africa. In total, we generated ~90,000 single cell RNASeq profiles and identified PBMC cell types affected by infection. Single cell RNASeq eQTL analysis revealed cell type specific eQTLs and genome-wide significant genotype-by-infection interaction effects implicating key immune genes. These results provide the first genome-wide picture of host in vivo regulatory variation events in malaria at the single cell level and highlight the implication of regulatory interaction effects in modulating host immune response in-vivo. 

Odmaa Bayaraa
New York University Abu Dhabi


Returning secondary genetic findings: Provider perspective in Africa

Objective: Previous research has shown that lack of resources and knowledge significantly impact the return of genomic test results. However, not much is known about the level of expertise and knowledge of clinicians providing cleft care in Africa on genetic diseases, despite the vast genetic diversity in this population.
Methods: Providers in participating cleft-craniofacial clinics in Ethiopia, Ghana, and Nigeria were sent the link to a 63-question online survey. This survey assessed the providers' experience with genetic testing, genetics education and return of genetic results, provider knowledge, clinician comfort with returning results, available resources to assist with genomic findings, and potential barriers.
Results: As of June 2nd, 2021, 246 providers completed the survey. Only 2% had been involved in the delivery of Exome or Genome sequencing; 78.6% had no formal genetic education, 49.6% agreed that all secondary findings should be disclosed to patients. Regarding the comfort level, 89.4% were somewhat to extremely comfortable discussing genetic risk factors with patients, and 81.8% were somewhat to extremely comfortable with returning genetic results. Sixty-three percent believed that resources were currently available to enable them to access needed genetic information.
Conclusion: Providers were aware that genetic testing could help in the clinical management of diseases from the returned responses. However, the lack of knowledge about genomic medicine, uncertain clinical utility, and lack of available resources were cited as barriers that significantly impacted incorporating genetic testing into their practice. Data collection is ongoing and will continue till July 31st, 2021. This is the first Ethical, Legal, and Social Implications (ELSI) study to document the knowledge and comfort level of cleft providers in Africa. This study will help determine the most beneficial information to equip providers with the return of secondary genetic findings. 

Abimbola Oladayo
University of Iowa